We are moving to a new home and we would love for you to visit us there. All of the tour posts and promotional articles have been moved and we are able to offer some new perks for our blog readers. It should also be easier to find what you need on the blog. It is very easy to subscribe - email or RSS feed - and we have a new search option.

Please visit us at http://bookpromotionservices.com/

Friday, April 4, 2008

Scientists Need to Explore All Cells to Find Treatment

Stem Cell Research: Scientists Will Need to Explore All Types of Cells to Find Treatment for More Illnesses and Conditions

Right to Recover: Winning the Political and Religious Wars over Stem Cell Research in America Compares Embryonic Stem Cells with Adult Stem Cells and Gives Reasons Why Both Should be Federally Funded

A new book written by Nashville author, Yvonne Perry, challenges preconceived religious and political ideas in hopes of changing the way Americans view blastocystic (embryonic) stem cell research. Right to Recover: Winning the Political and Religious Wars over Stem Cell Research in America (ISBN: 978-1-933449-41-8) was released on October 1 by Nightengale Press to coincide with the start up of the 2008 presidential election campaigns.

The book contains biological facts and scientific data about all types of stem cell research in a way that most people can understand. One question Perry poses in her book is this: “If cord blood, amniotic fluid, and bone marrow contain stem cells, and there is no controversial issue with these cells, then why do we need research on blastocyst (embryonic) stem cells?”

The simple truth is there are no substitutes for pluripotent stem cells. While cord blood, amniotic fluid, adult stem cells, reprogramming of cells and other alternate research certainly deserve study, no credible expert supports using them as a replacement for blastocysts stem cells leftover from in-vitro fertilization. Each type of cell has its own unique characteristics and abilities.

There are no moral issues attached to the use of cord blood and amniotic fluid, but like adult stem cells, these have already differentiated and have different characteristics than in-vitro blastocyst (IV-B) stem cells. Days-old blastocyst stem cells allow a range of research on the very earliest stages of human development and are more versatile than adult stem cells or fetal cells extracted months later from amniotic fluid or from cord blood at birth.

Scientists are still trying to discover which set of stem cell characteristics will ultimately be needed to cure or treat certain diseases. Here are a few key features we know about IV-B stem cells and adult stem cells (ASC):

IV-B stem cells are indefinite, robust, and self-renewable. IV-B stem cells can transform into virtually any type of cell of the body. Pluripotency disappears as differentiation occurs and development continues.

ASCs are limited in the number of cells they are able to transform into; in other words, they can only create more of the same type of cells as they already are. For that reason, adult cells are not able to do the same things as IV-B stem cells, which have the characteristics researchers believe are needed to cure some diseases.

Stem cells exist in relatively large numbers in IV-Bs. IV-Bs will not always be needed once a stem cell line of every race and condition is created by nuclear transfer cloning.

ASC or multipotent progenitor stem cells have not yet been found in all tissues of the body. In fact, they are scarce in the brain. If neural stem cells are needed, they must be generated from blastocyst stem cells. Bone marrow stem cells must be revved up with medication to stimulate their growth before they can be used for transplantation in the treatment of cancer.

Any knowledge gained from blastocyst stem cells will complement studies of adult and all other types of stem cells, and vice versa. Most scientists agree that therapy advances will be found by responsibly investigating all aspects of stem cell biology.

“Regardless of whether the therapies come from adult stem cells, cord blood, amniotic fluid, or IV-B research, all of humanity stands to profit from stem cell treatment and technology,” says Perry. “Whether it comes from the U.S. or another country, the cure for Alzheimer’s, Parkinson’s, heart disease, spinal cord injury, diabetes, or other illness or injuries is within reach.”

With a foreword by Dr. Evan Snyder of Burnham Institute and endorsements from Cure Paralysis Now, Don C. Reed of California’s Prop 71, Christopher Reeve Foundation, and many others, Perry’s book, while controversial, is a concise and accurate picture of the biology and legislation regarding stem cell research in the U.S and globally. For more information about the book see www.right2recover.com

Reverend Dan Bloodworth of The Brian Bloodworth Stroke and Head Injury Research Foundation gave Ms. Perry Biblical references to support blastocystic stem cell research. An entire chapter is dedicated to helping Christians understand this incredible gift God has given humanity. Rev. Bloodworth says, “It is such a pleasure to work with a writer like Yvonne Perry.

She has truly researched the research and spent hundreds of hours to find the facts to share with the readers of RIGHT TO RECOVER. Over the years I have read literally thousands of articles and documents from around the world about this subject and RIGHT TO RECOVER is the most complete work I have ever read. It provides an honest evaluation and asks readers to consider the facts and then form their own opinion instead of listening to people who have never researched the subject.”

To purchase the book online go to www.nightengalepress.com or amazon.com. The book may be ordered in bookstores as well.

Posted by:
Nikki Leigh
Author of the Book Promo 101 Series

No comments: